Skip to main content
Premium Trial:

Request an Annual Quote

Mayo Clinic's Minnesota Branch Lands $3M for Genomics Research

NEW YORK (GenomeWeb News) - Two Minnesota foundations have awarded a total of $3 million to Mayo Clinic's Rochester branch for genomics research, the Mayo Clinic said yesterday.
 
The clinic will receive $2 million from the Curtis L. Carlson Family Foundation to endow the Carlson Family Professorship in Genomics Research and $1 million from the Nelson Family Foundation to establish the Nelson Family Genomics Research Fund.
 
Mayo Clinic also said it will toss another $3 million of its own funds into the genomics programs under a matching arrangement.
 
The foundations were created by Marilyn Carlson Nelson and her husband, Glen Nelson.
 
The foundation gifts will be used to "strengthen Mayo's position in genomics research and complement the work now being done by the Minnesota Partnership," said Mayo Clinic Rochester CEO Glenn Forbes.
 
The Minnesota Partnership is a joint effort between Mayo Clinic and the University of Minnesota and is "an important factor in Minnesota's goal to become a national leader in genomics research," the clinic said.

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.